BR102015011079A2 - palmitoiletanolamida em forma não micronizada, em forma micronizada (pea-m), em forma ultramicronizada (pea-um) ou misturas das mesmas e composição farmacêutica ou veterinária - Google Patents

palmitoiletanolamida em forma não micronizada, em forma micronizada (pea-m), em forma ultramicronizada (pea-um) ou misturas das mesmas e composição farmacêutica ou veterinária Download PDF

Info

Publication number
BR102015011079A2
BR102015011079A2 BR102015011079A BR102015011079A BR102015011079A2 BR 102015011079 A2 BR102015011079 A2 BR 102015011079A2 BR 102015011079 A BR102015011079 A BR 102015011079A BR 102015011079 A BR102015011079 A BR 102015011079A BR 102015011079 A2 BR102015011079 A2 BR 102015011079A2
Authority
BR
Brazil
Prior art keywords
opioid
palmitoylethanolamide
palmitoiletanolamide
pea
micronized
Prior art date
Application number
BR102015011079A
Other languages
English (en)
Portuguese (pt)
Inventor
Carla Ghelardini
Francesco Della Valle
Lorenzo Di Cesare Manelli
Maria Federica Della Valle
Original Assignee
Epitech Group Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epitech Group Srl filed Critical Epitech Group Srl
Publication of BR102015011079A2 publication Critical patent/BR102015011079A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dispersion Chemistry (AREA)
BR102015011079A 2014-05-14 2015-05-14 palmitoiletanolamida em forma não micronizada, em forma micronizada (pea-m), em forma ultramicronizada (pea-um) ou misturas das mesmas e composição farmacêutica ou veterinária BR102015011079A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI20140876 2014-05-14

Publications (1)

Publication Number Publication Date
BR102015011079A2 true BR102015011079A2 (pt) 2016-03-29

Family

ID=51179022

Family Applications (1)

Application Number Title Priority Date Filing Date
BR102015011079A BR102015011079A2 (pt) 2014-05-14 2015-05-14 palmitoiletanolamida em forma não micronizada, em forma micronizada (pea-m), em forma ultramicronizada (pea-um) ou misturas das mesmas e composição farmacêutica ou veterinária

Country Status (17)

Country Link
US (1) US9801836B2 (enExample)
EP (1) EP2944309B1 (enExample)
JP (1) JP6563685B2 (enExample)
KR (1) KR102507891B1 (enExample)
CN (1) CN105079811B (enExample)
AR (1) AR100444A1 (enExample)
AU (1) AU2015202575B9 (enExample)
BR (1) BR102015011079A2 (enExample)
CA (1) CA2891049C (enExample)
CY (1) CY1121773T1 (enExample)
DK (1) DK2944309T3 (enExample)
ES (1) ES2731729T3 (enExample)
HU (1) HUE044915T2 (enExample)
PL (1) PL2944309T3 (enExample)
PT (1) PT2944309T (enExample)
SM (1) SMT201900345T1 (enExample)
TR (1) TR201908936T4 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL322263A (en) * 2015-05-21 2025-09-01 Scisparc Ltd Combinations of opioids and acetylamines
PH12018000077B1 (en) 2017-07-05 2021-07-09 Frimline Private Ltd A pharmaceutical composition for neuropathic pain
PH12018000227A1 (en) 2017-09-05 2019-03-11 Frimline Private Ltd A pharmaceutical composition for improving or preventing progression of chronic kidney disease
WO2020141546A1 (en) * 2019-01-02 2020-07-09 Celagenex Research (India) Pvt. Ltd. Synergistic nutritional compositions for pain management

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1271266B (it) 1994-12-14 1997-05-27 Valle Francesco Della Impiego terapeutico di ammidi di acidi mono e bicarbossilici con amminoalcoli,selettivamente attive sul recettore periferico dei cannabinoidi
US6548550B1 (en) 1999-08-06 2003-04-15 Innovet Italia S.R.L. Pharmaceutical compositions containing N-palmitoylethanolamide and use thereof in the veterinary field
ES2312643T5 (es) * 2001-07-18 2011-10-18 Unilever N.V. Composiciones para el tratamiento del cabello y/o del cuero cabelludo.
US20050245557A1 (en) * 2003-10-15 2005-11-03 Pain Therapeutics, Inc. Methods and materials useful for the treatment of arthritic conditions, inflammation associated with a chronic condition or chronic pain
JP2012522004A (ja) * 2009-03-27 2012-09-20 アボット・ラボラトリーズ カンナビノイド受容体リガンドである化合物
PL2796129T3 (pl) * 2009-09-07 2015-11-30 Epitech Group S P A Kompozycja zawierająca palmitoiloetanoloamid poddany ultramikronizacji

Also Published As

Publication number Publication date
KR102507891B1 (ko) 2023-03-08
AR100444A1 (es) 2016-10-05
KR20150130931A (ko) 2015-11-24
CA2891049C (en) 2023-02-21
CA2891049A1 (en) 2015-11-14
DK2944309T3 (da) 2019-06-03
PL2944309T3 (pl) 2019-09-30
CN105079811B (zh) 2020-06-23
CN105079811A (zh) 2015-11-25
PT2944309T (pt) 2019-06-05
AU2015202575A1 (en) 2015-12-03
JP6563685B2 (ja) 2019-08-21
AU2015202575B9 (en) 2020-03-26
US20150328173A1 (en) 2015-11-19
HUE044915T2 (hu) 2019-11-28
SMT201900345T1 (it) 2019-07-11
US9801836B2 (en) 2017-10-31
TR201908936T4 (tr) 2019-07-22
AU2015202575B2 (en) 2020-03-05
CY1121773T1 (el) 2020-07-31
ES2731729T3 (es) 2019-11-18
EP2944309A1 (en) 2015-11-18
JP2015221794A (ja) 2015-12-10
EP2944309B1 (en) 2019-03-20

Similar Documents

Publication Publication Date Title
EP2964022B1 (en) Pain medicine combination and uses thereof
JP6216305B2 (ja) 薬物過量摂取の治療のためのモルヒナン誘導体
US5256669A (en) Methods and compositions for treating acute or chronic pain and drug addiction
US10517841B1 (en) Compositions and methods for treating respiratory depression with fenfluramine
CN109689058B (zh) 治疗和预防睡眠障碍
KR950002746A (ko) 방출억제성 오피오이드 제형
MX2012013380A (es) Atomizador nasal liquido que contiene naltresona de dosis baja.
BR102015011079A2 (pt) palmitoiletanolamida em forma não micronizada, em forma micronizada (pea-m), em forma ultramicronizada (pea-um) ou misturas das mesmas e composição farmacêutica ou veterinária
KR20240160681A (ko) 수면 장애 치료 및 예방
EP2130539A1 (en) Therapeutic tablet for postherpetic neuralgia and method of treating postherpetic neuralgia
EP3590511A1 (en) Therapeutic agent for alcohol use disorders
WO2007043518A1 (ja) 嘔気および／または嘔吐治療剤
JPWO1997006139A1 (ja) 麻薬性鎮痛剤の依存・耐性形成抑制剤
HK1217408B (en) Pain medicine combination and uses thereof
CN101945650A (zh) 含有大麻素受体结合化合物和阿片类化合物的组合产品
BR102014003686A2 (pt) composição farmacêutica oral estável
BR102013032395A2 (pt) Composição farmacêutica oral estável

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07F Notification of approval that there is no relation to art. 229 of lpi (pipeline patents) [chapter 7.6 patent gazette]
B11R Patent application dismissed according to article 229 of the patent law [chapter 11.18 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2670 DE 08-03-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.